Home›Stock Screener›Genesis IBRC›P/B Ratio

Genesis IBRC P/B Ratio

Current P/B Ratio
9.06
High Valuation
Very High - Significant premium, high growth expectations or speculative

Genesis IBRC (GENESIS) P/B ratio is 9.06 (High), book value per share ₹7.69 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. View GENESIS price range for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 9.06
Current Price ₹85.36
Book Value/Share ₹7.69
Exchange BSE

Book Value Breakdown (2018)

Balance Sheet Components
Total Equity ₹10 Cr
Share Capital ₹13 Cr
Reserves & Surplus ₹-3 Cr
Outstanding Shares 13,000,000
Book Value per Share ₹7.69

Valuation Signal

Signal Overvalued
Historical Avg 0.75
Historical Range 0.75 - 0.75
Percentile 100.0%

Sector Context

Sector Average -0.33
Sector Median 0.6
Sector Rank #11 of 50
Sector Percentile 22.0%

GENESIS P/B Ratio — Valuation Insights & Book Value Analysis

Genesis IBRC price-to-book ratio interpretation, valuation status and historical context — current P/B 9.06 (High). For live price, earnings yield and the full fundamental profile, see Genesis IBRC share price today.

  • Stock appears overvalued with PB of 9.06, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 1108.0% above historical average
  • Trading at premium to sector average PB of -0.33

Genesis IBRC P/B Ratio Historical Trend

GENESIS annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review GENESIS PE ratio trends to evaluate earnings-based valuation against sector peers.

GENESIS Historical P/B Ratio — Book Value Per Share & Year-End Price

Genesis IBRC annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2018 0.75 ₹7.69 ₹5.80 ₹10 Low

GENESIS vs Healthcare Peers — P/B Ratio Comparison

Genesis IBRC P/B 9.06 vs Healthcare average -0.33, median 0.6 — range -17.45–1.11.

Sector Average
-0.33
Sector Median
0.6
Lowest P/B
-17.45
Highest P/B
1.11
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.45 ₹21 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Parmax Pharma PARMAX -4.18 ₹29 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.34 ₹75 Low
Krebs Biochemicals & Ind… KREBSBIO -0.88 ₹132 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.56 ₹50 Low